The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Abstract
Purpose: To analyze recurrence patterns in patients with cancer of the esophagus or gastroesophageal junction treated with either preoperative chemoradiotherapy (CRT) plus surgery or surgery alone. Patients and Methods: Recurrence pattern was analyzed in patients from the previously published CROSS I and II trials in relation to radiation target volumes. CRT consisted of five weekly courses of paclitaxel and carboplatin combined with a concurrent radiation dose of 41.4 Gy in 1.8-Gy fractions to the tumor and pathologic lymph nodes with margin. Results: Of the 422 patients included from 2001 to 2008, 418 were available for analysis. Histology was mostly adenocarcinoma (75%). Of the 374 patients who underwent resection, 86% were allocated to surgery and 92% to CRT plus surgery. On January 1, 2011, after a minimum follow-up of 24 months (median, 45 months), the overall recurrence rate in the surgery arm was 58% versus 35% in the CRT plus surgery arm. Preoperative CRT reduced locoregional recurrence (LRR) from 34% to 14% (P < .001) and peritoneal carcinomatosis from 14% to 4% (P < .001). There was a small but significant effect on hematogenous dissemination in favor of the CRT group (35% v 29%; P = .025). LRR occurred in 5% within the target volume, in 2% in the margins, and in 6% outside the radiation target volume. In 1%, the exact site in relation to the target volume was unclear. Only 1% had an isolated infield recurrence after CRT plus surgery. Conclusion: Preoperative CRT in patients with esophageal cancer reduced LRR and peritoneal carcinomatosis. Recurrence within the radiation target volume occurred in only 5%, mostly combined with outfield failures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Cited by
Markar, S., Gronnier, C., Duhamel, A., Mabrut, J.-Y., Bail, J.-P., Carrere, N., Lefevre, J. H., Brigand, C., Vaillant, J.-C., Adham, M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001011 · Cited by 320
Stahl, M., Walz, M. K., Riera-Knorrenschild, J., Stuschke, M., Sandermann, A., Bitzer, M., Wilke, H., & Budach, W. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.04.027 · Cited by 283
Metadata
- Authors
- Oppedijk, V., van der Gaast, A., van Lanschot, J. J. B., van Hagen, P., van Os, R., van Rij, C. M., van der Sangen, M. J., Beukema, J. C., Rütten, H., Spruit, P. H., Reinders, J. G., Richel, D. J., van Berge Henegouwen, M. I., & Hulshof, M. C. C. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-02-10
- Volume
- 32
- Issue
- 5
- Pages
- 385-391
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2137696504
- Cited by
- 502
- References
- 1
- FWCI
- 43.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials. https://app.cochat.ai/papers/10.1200/jco.2013.51.2186
- The paper
- Oppedijk, V., van der Gaast, A., van Lanschot, J. J. B., van Hagen, P., van Os, R., van Rij, C. M., van der Sangen, M. J., Beukema, J. C., Rütten, H., Spruit, P. H., Reinders, J. G., Richel, D. J., van Berge Henegouwen, M. I., & Hulshof, M. C. C. M. (2014). Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2013.51.2186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
